Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A S Vorstman

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cytogenetic and Genome Research|November 8, 2011
Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and researchR Hochstenbach, J E Buizer-Voskamp, J A S Vorstman, et al.
Clinical Genetics|February 27, 2016
The role of COMT and plasma proline in the variable penetrance of autistic spectrum symptoms in 22q11.2 deletion syndromeE Hidding, H Swaab, L M J de Sonneville, et al.
Tijdschrift Voor Psychiatrie|June 23, 2022
[Guidelines on genetic testing in psychiatry: an overview]M Z van der Horst, C M Aalfs, J A S Vorstman, et al.
Human Mutation|June 23, 2006
MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22qJ A S Vorstman, G R Jalali, E F Rappaport, et al.
Human Mutation|November 23, 2007
Detailed analysis of 22q11.2 with a high density MLPA probe setG R Jalali, J A S Vorstman, Ab Errami, et al.
Molecular Psychiatry|October 6, 2005
Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autismJ A S Vorstman, W G Staal, E van Daalen, et al.
Schizophrenia Research|January 26, 2017
Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal studyA M Fiksinski, E J Breetvelt, S N Duijff, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 14, 2002
[A bifid uvula in a patient with schizophrenia as a sign of 22q11 deletion syndrome]J A S Vorstman, A G S de Ranitz, F E A Udink ten Cate, et al.
Pharmacopsychiatry|June 20, 2015
Pharmacological treatment of 22q11.2 deletion syndrome-related psychosesE Boot, N J Butcher, J A S Vorstman, et al.
American Journal of Medical Genetics. Part A|February 24, 2007
Behavioral problems in relation to intelligence in children with 22q11.2 deletion syndrome: a matched control studyP W Jansen, S N Duijff, F A Beemer, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cytogenetic and Genome Research|November 8, 2011
Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and researchR Hochstenbach, J E Buizer-Voskamp, J A S Vorstman, et al.
Clinical Genetics|February 27, 2016
The role of COMT and plasma proline in the variable penetrance of autistic spectrum symptoms in 22q11.2 deletion syndromeE Hidding, H Swaab, L M J de Sonneville, et al.
Tijdschrift Voor Psychiatrie|June 23, 2022
[Guidelines on genetic testing in psychiatry: an overview]M Z van der Horst, C M Aalfs, J A S Vorstman, et al.
Human Mutation|June 23, 2006
MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22qJ A S Vorstman, G R Jalali, E F Rappaport, et al.
Human Mutation|November 23, 2007
Detailed analysis of 22q11.2 with a high density MLPA probe setG R Jalali, J A S Vorstman, Ab Errami, et al.
Molecular Psychiatry|October 6, 2005
Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autismJ A S Vorstman, W G Staal, E van Daalen, et al.
Schizophrenia Research|January 26, 2017
Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal studyA M Fiksinski, E J Breetvelt, S N Duijff, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 14, 2002
[A bifid uvula in a patient with schizophrenia as a sign of 22q11 deletion syndrome]J A S Vorstman, A G S de Ranitz, F E A Udink ten Cate, et al.
Pharmacopsychiatry|June 20, 2015
Pharmacological treatment of 22q11.2 deletion syndrome-related psychosesE Boot, N J Butcher, J A S Vorstman, et al.
American Journal of Medical Genetics. Part A|February 24, 2007
Behavioral problems in relation to intelligence in children with 22q11.2 deletion syndrome: a matched control studyP W Jansen, S N Duijff, F A Beemer, et al.
Pageof 2